Boxer Capital LLC 13D and 13G filings for iTeos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-15 9:49 pm Purchase | 2024-10-10 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 3,020,052 8.100% | 73,137 (+2.48%) | Filing |
| 2024-05-15 08:37 am Purchase | 2024-05-10 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 2,946,915 8.100% | 792,857 (+36.81%) | Filing |
| 2022-05-11 5:14 pm Sale | 2022-05-09 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 2,154,058 6.100% | -988,000 (-31.44%) | Filing |
| 2022-03-18 9:00 pm Sale | 2022-03-17 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 3,142,058 8.900% | -575,201 (-15.47%) | Filing |
| 2022-01-05 9:26 pm Sale | 2022-01-03 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 3,717,259 10.540% | -627,757 (-14.45%) | Filing |
| 2020-08-07 5:15 pm Purchase | 2020-07-28 | 13D | iTeos Therapeutics, Inc. ITOS | Boxer Capital LLC | 4,345,016 13.000% | 4,345,016 (New Position) | Filing |